Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gal Markel

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Cell|September 10, 2019
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial DependenceMichal Harel, Rona Ortenberg, Siva Karthik Varanasi, et al.
Journal for Immunotherapy of Cancer|November 7, 2024
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunctionDavid W Vredevoogd, Georgi Apriamashvili, Pierre L Levy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2021
Impact of <i>TP53</i> Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell TherapyRoni Shouval, Ana Alarcon Tomas, Joshua A Fein, et al.
Nature Cell Biology|February 17, 2015
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasisEinav Shoshan, Aaron K Mobley, Russell R Braeuer, et al.
Science (New York, N.Y.)|December 11, 2020
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patientsErez N Baruch, Ilan Youngster, Guy Ben-Betzalel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2019
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel DiseaseHamzah Abu-Sbeih, David M Faleck, Biagio Ricciuti, et al.
Cancer Cell|March 15, 2024
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitnessChun-Pu Lin, Pierre L Levy, Astrid Alflen, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Cell|September 10, 2019
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial DependenceMichal Harel, Rona Ortenberg, Siva Karthik Varanasi, et al.
Journal for Immunotherapy of Cancer|November 7, 2024
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunctionDavid W Vredevoogd, Georgi Apriamashvili, Pierre L Levy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2021
Impact of <i>TP53</i> Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell TherapyRoni Shouval, Ana Alarcon Tomas, Joshua A Fein, et al.
Nature Cell Biology|February 17, 2015
Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasisEinav Shoshan, Aaron K Mobley, Russell R Braeuer, et al.
Science (New York, N.Y.)|December 11, 2020
Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patientsErez N Baruch, Ilan Youngster, Guy Ben-Betzalel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2019
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel DiseaseHamzah Abu-Sbeih, David M Faleck, Biagio Ricciuti, et al.
Cancer Cell|March 15, 2024
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitnessChun-Pu Lin, Pierre L Levy, Astrid Alflen, et al.
Pageof 14